185 related articles for article (PubMed ID: 12873566)
1. Barrett's esophagus evokes a quantitatively and qualitatively altered response to both acid and hypertonic solutions.
Fletcher J; Gillen D; Wirz A; McColl KE
Am J Gastroenterol; 2003 Jul; 98(7):1480-6. PubMed ID: 12873566
[TBL] [Abstract][Full Text] [Related]
2. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
[TBL] [Abstract][Full Text] [Related]
3. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
Triadafilopoulos G; Kaczynska M; Iwane M
Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
[TBL] [Abstract][Full Text] [Related]
4. Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis?
Coenraad M; Masclee AA; Straathof JW; Ganesh S; Griffioen G; Lamers CB
Am J Gastroenterol; 1998 Jul; 93(7):1068-72. PubMed ID: 9672332
[TBL] [Abstract][Full Text] [Related]
5. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present.
Singh P; Taylor RH; Colin-Jones DG
Am J Gastroenterol; 1994 Mar; 89(3):349-56. PubMed ID: 8122643
[TBL] [Abstract][Full Text] [Related]
6. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
Sharma P; Sampliner RE; Camargo E
Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
[TBL] [Abstract][Full Text] [Related]
7. [Association between symptomatic gastroesophageal reflux and Barrett's esophagus].
Trujillo-Benavides OE; Baltazar-Montúfar P; Angeles-Garay U; Ramírez-Mendoza P; Navarro-García AM; Paredes-Cruz E; Méndez del Monte R; Guerrero-Hernández M
Rev Gastroenterol Mex; 2005; 70(1):14-9. PubMed ID: 16170957
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus.
Eloubeidi MA; Provenzale D
Am J Gastroenterol; 2000 Aug; 95(8):1881-7. PubMed ID: 10950030
[TBL] [Abstract][Full Text] [Related]
9. Bile and acid reflux in long and short segment Barrett's esophagus, and in reflux disease.
Pfaffenbach B; Hullerum J; Orth KH; Langer M; Stabenow-Lohbauer U; Lux G
Z Gastroenterol; 2000 Jul; 38(7):565-70. PubMed ID: 10965553
[TBL] [Abstract][Full Text] [Related]
10. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus.
Ouatu-Lascar R; Triadafilopoulos G
Am J Gastroenterol; 1998 May; 93(5):711-6. PubMed ID: 9625114
[TBL] [Abstract][Full Text] [Related]
11. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
12. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus.
Hak NG; Mostafa M; Salah T; El-Hemaly M; Haleem M; Abd El-Raouf A; Hamdy E
Hepatogastroenterology; 2008; 55(82-83):442-7. PubMed ID: 18613384
[TBL] [Abstract][Full Text] [Related]
13. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
14. Abdominal obesity and body mass index as risk factors for Barrett's esophagus.
Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Quesenberry C; Rumore GJ; Buffler PA
Gastroenterology; 2007 Jul; 133(1):34-41; quiz 311. PubMed ID: 17631128
[TBL] [Abstract][Full Text] [Related]
15. Symptoms, acid exposure and motility in patients with Barrett's esophagus.
Brandt MG; Darling GE; Miller L
Can J Surg; 2004 Feb; 47(1):47-51. PubMed ID: 14997925
[TBL] [Abstract][Full Text] [Related]
16. Does Barrett's esophagus impact outcome after laparoscopic Nissen fundoplication?
Cowgill SM; Al-Saadi S; Villadolid D; Zervos EE; Rosemurgy AS
Am J Surg; 2006 Nov; 192(5):622-6. PubMed ID: 17071195
[TBL] [Abstract][Full Text] [Related]
17. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
[TBL] [Abstract][Full Text] [Related]
18. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus.
Katzka DA; Castell DO
Am J Gastroenterol; 1994 Jul; 89(7):989-91. PubMed ID: 8017396
[TBL] [Abstract][Full Text] [Related]
19. Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium.
Tharalson EF; Martinez SD; Garewal HS; Sampliner RE; Cui H; Pulliam G; Fass R
Am J Gastroenterol; 2002 Apr; 97(4):851-6. PubMed ID: 12003418
[TBL] [Abstract][Full Text] [Related]
20. Patients with Barrett's esophagus are hypersensitive to acid but hyposensitive to other stimuli compared with healthy controls.
Lottrup C; Krarup AL; Gregersen H; Ejstrud P; Drewes AM
Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27891754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
